Swift SARS-CoV-2 Amplicon Panel: NGS in a SNAP
When:
Tuesday 16th June, 2020 at 2pm
Speakers:
Dr. Kayla Peck, Senior R&D Scientist, Swift Biosciences
Dr. Jon Irish, Director of Data Sciences, Swift Biosciences
The emergence of SARS-CoV-2 has resulted in the need for NGS strategies for characterizing the viral genome. Sequencing of the full-length genome is critical for identifying mutational variants and contributing to research in the fields of virology, immunology, epidemiology, and molecular evolution, among others. However, maximizing viral RNA sequencing reads from clinical specimens can be challenging, particularly due to the amount of human background that may be present. In this webinar, you will learn about a targeted NGS strategy which features the new Swift Normalase™ Amplicon Panel (SNAP) workflow using a SARS-CoV-2 specific panel. The SNAP SARS-CoV-2 kit shows high yields and data quality across a wide range of viral copy numbers, facilitating confident mutation detection from low input samples. The SNAP single-tube workflow allows you to go from cDNA to a normalized library pool, providing an efficient, cost-effective, and high-throughput-friendly approach for your SARS-CoV-2 NGS research.